• A 83-01 ALK Inhibitor: Fibrosis Assay Workflows

  2026-08-24

  A 83-01 is a practical ALK-5 inhibitor for separating TGF-β/Smad activity from broader changes in fibrosis, EMT, and cell growth assays. This guide converts its biochemical profile into reproducible dosing, controls, troubleshooting steps, and a kidney-fibrosis workflow informed by single-cell research.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-08-23

  A 2026 study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast ferroptosis with defective syncytialization in preeclampsia. Its data suggest that increasing O-GlcNAc modification stabilizes HUWE1, promotes TfR1 ubiquitination and degradation, limits iron uptake, and improves placental and pregnancy-related outcomes in experimental models.

• IR-820 Near-Infrared Imaging: Practical Workflows

  2026-08-22

  IR-820 (New Indocyanine Green) supports quantitative vascular and tumor imaging with a practical path from concentration screening to live-animal time-course analysis. This guide also explains how to evaluate its imaging role alongside photothermal-immunotherapy platforms without assuming that data generated with conventional ICG automatically transfer to IR-820.

• Ibrexafungerp Against Echinocandin-Resistant Candida

  2026-08-21

  This study tested ibrexafungerp across 192 clinically derived Candida isolates with phenotypic or genotypic echinocandin resistance, linking susceptibility patterns to specific FKS hotspot mutations. The results support activity against several resistant backgrounds while showing that mutation position and species strongly influence ibrexafungerp MIC distributions and wild-type classification.

• Caspase-3 Fluorometric Assay Kit: Practical Guide

  2026-08-20

  Learn how to use the Caspase-3 Fluorometric Assay Kit for rapid, quantitative apoptosis profiling and mechanistic studies of chemotherapy–hyperthermia combinations. The workflow connects DEVD-dependent caspase activity detection with treatment controls, orthogonal cell-death assays, and troubleshooting strategies for reproducible bench results.

• H 89 2HCl in cAMP/PKA Osteoclast Assays

  2026-08-20

  H 89 2HCl helps researchers distinguish PKA-dependent phosphorylation from upstream cAMP production in osteoclast and other cellular models. This workflow-focused guide shows how to use concentration controls, pathway rescue experiments, and orthogonal readouts to interpret cAMP/PKA signaling with greater confidence.

• Anemoside B4, CD1d, and NLRP3 in Colitis

  2026-08-19

  This preprint identifies a macrophage-centered mechanism by which Anemoside B4 alleviates DSS-induced colitis: suppression of CD1d-dependent NLRP3 inflammasome activation through the AKT-STAT1-PRDX1-NF-κB axis. Its use of NLRP3-deficient mice, isolated intestinal cell populations, and macrophage-specific CD1d depletion provides a mechanistic framework for interpreting natural-product activity in intestinal inflammation research.

• Schlafen-11/9 Sense Intracellular ssDNA

  2026-08-19

  A recent preprint identifies Schlafen-11 as a sequence-selective sensor of intracellular single-stranded DNA containing CGT motifs and links its murine homolog, Schlafen-9, to inflammatory disease phenotypes. The study combines unbiased genetic screening, biochemical validation, cell-based immune assays, and mouse models to expand the known landscape of nucleic-acid pattern recognition.

• Rotigotine Workflows for Parkinson’s Research

  2026-08-18

  Rotigotine supports more than receptor activation studies: it connects dopamine signaling, oxidative-stress assays, disease models, and formulation stability workflows. This guide provides practical starting conditions, analytical safeguards, and troubleshooting strategies for translational Parkinson’s disease research.

• HRD1-SEL1L, p97, and Stress Granule Homeostasis

  2026-08-18

  The 2024 iScience study identifies the HRD1-SEL1L ubiquitin ligase complex as a selective regulator of heat shock-induced stress granule homeostasis. Its mechanistic model connects ER quality control, the UPS-associated ATPase p97, and the BiP-PERK-eIF2α branch of the unfolded protein response, while showing that ER-stress pathways do not have interchangeable effects on stress granules.

• Doxorubicin: From DNA Damage to Translation

  2026-08-17

  Doxorubicin, also known as Adriamycin, remains a powerful translational benchmark because it connects DNA topoisomerase II inhibition, chromatin disruption, DNA damage, and apoptosis with clinically relevant questions in oncology. This thought-leadership guide shows how to use the compound strategically across mechanistic studies, combination research, disease modeling, and early safety translation.

• Rotigotine: Dopamine and Bladder Circuits in PD

  2026-08-16

  Rotigotine is a dopamine D2/D3 receptor agonist with unusually broad dopaminergic activity. This article examines how route, timing, and lower-urinary-tract readouts can reveal treatment mechanisms that conventional Parkinson’s disease assays may overlook.

• Bedaquiline for Reproducible Cell Assays

  2026-08-15

  A scenario-based guide to using Bedaquiline (SKU B3492) in tuberculosis and cancer-cell viability workflows. It explains how mitochondrial effects, stock handling, orthogonal readouts, and supplier documentation influence assay interpretation and reproducibility.

• Cdc42 Signaling and Kidney Fibrosis: Study Insights

  2026-08-15

  The 2024 Advanced Science study identified the natural daphne diterpenoid daphnepedunin A as an anti-fibrotic lead that acts through Cdc42-mediated GSK-3β/β-catenin signaling. Its combination of bioassay-guided chemistry, thermal proteome profiling, renal fibroblast assays, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42 as a kidney-fibrosis target.

• Resazurin sodium salt for Cell Metabolism Assays

  2026-08-14

  Resazurin sodium salt converts cellular redox activity into a sensitive red-fluorescent signal for viability, proliferation, and cytotoxicity workflows. Its strongest use is as a flexible metabolic readout in intestinal L-cell models, cancer cell line toxicity assessment, flow cytometry, microscopy, and high-throughput screening—provided exposure time, solvent, and signal linearity are controlled.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page